Obesity Trial, Recruiting NCT07144800 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07144800
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Phase 1 (Adult participants)

  • People aged 18 or older
  • People who identify as Hispanic or Latino
  • People who have sought or used services at the VDS or MHU (confirm with trial site for details on these services)
  • People who are a parent or primary caregiver for at least one child aged 8–12 living in their home
  • People who are overweight (BMI 25–29.9) or obese (BMI over 30), measured in person or by self-report
  • People who own a mobile phone that can receive text messages
  • People who own an internet-connected device (such as a phone or tablet) that can make video calls
  • People who agree to have their participation audio-recorded

Phase 2 (Adult/parent participants)

  • The same criteria as Phase 1 apply, with the addition that BMI may be measured remotely

Phase 2 (Child participants)

  • Children aged 8–12 years old
  • Children whose parent or primary caregiver is eligible for and taking part in Phase 2 of the trial

Who may not be able to join:

Phase 1 (Adult participants)

  • People who are pregnant or think they may be pregnant
  • People living with a chronic illness such as cancer, kidney disease, or liver disease that may affect their diet or ability to take part (note: people with high blood pressure or diabetes may still be considered eligible)
  • People who follow strict dietary restrictions, such as a liquid-only diet, that could affect their participation
  • People who have a household member who has already joined or agreed to join this study
  • People who previously took part in related studies such as COMIDA, SANOS, or Family COMIDA, or any related focus groups
  • People who work for or alongside the VDS or MHU
  • People with a cognitive impairment, such as dementia or delirium, that would make it difficult to meaningfully consent to or take part in the study (as assessed by the study team)

Phase 2 (Adult/parent participants)

  • All of the same exclusions as Phase 1 apply
  • Women who are currently breastfeeding
  • People with physical limitations, such as mobility issues, that may prevent them from increasing their physical activity levels (such as increasing daily steps)

Phase 2 (Child participants)

  • Children who follow strict dietary restrictions, such as a liquid-only diet, that could affect their participation
  • Children who have physical limitations, such as mobility issues, that may prevent them from taking part in physical activity
  • Children who have an eating disorder
  • Children who are underweight

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jennifer Leng, MD, MPH, Memorial Sloan Kettering Cancer Center

Phone: 646-888-8057

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 August 2025
Est. completion
31 July 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage weight loss from baseline among participants

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov